0001140377-01-500130.txt : 20011106
0001140377-01-500130.hdr.sgml : 20011106
ACCESSION NUMBER: 0001140377-01-500130
CONFORMED SUBMISSION TYPE: NT 10-K
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20011031
FILED AS OF DATE: 20011101
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIO PULSE INTERNATIONAL INC
CENTRAL INDEX KEY: 0001102939
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SOCIAL SERVICES [8300]
IRS NUMBER: 870634278
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: NT 10-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-28973
FILM NUMBER: 1772780
BUSINESS ADDRESS:
STREET 1: 10421 SOUTH JORDAN GATEWAY
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84095
BUSINESS PHONE: 8015230101
MAIL ADDRESS:
STREET 1: 10421 SOUTH JORDAN GATEWAY
STREET 2: SUITE 500
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84095
NT 10-K
1
biiextk.txt
FORM NT 10K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 12b-25
NOTIFICATION OF LATE FILING
X Form 10-K Form 20-F Form 11-K Form 10-Q Form N-SAR
----- --- --- --- ---
Commission file number 0-28973
BioPulse International, Inc.
------------------------------
Full Name of Registrant
N/A
Former Name of Registrant
10421 South Jordan Gateway, Suite 500
---------------------------------------
Address of Principle Executive Offices
(street and number)
South Jordan, Utah 84095
-------------------------------------
City, State and Zip Code
Part II - Rules 12b-25 (b) and (c)
If the subject could be filed without unreasonable effort or expense and
the Registrant seeks relief pursuant to Rule 12b-25 (b), the following
should be completed. (Check if appropriate).
(a) The reasons described in reasonable detail in Part III of this
---- form could not be eliminated without unreasonable effort of
expense;
X (b) The subject annual report, semi-annual report, transition report
---- on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or portion
thereof, will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q, or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statements or other exhibit required by Rule
---- 12b-25 (c) has been attached if applicable.
Part III - Narrative
The Company was delayed in compiling certain financial information
necessary for it to complete its 10QSB for the period ended April 31, 2001.
The Company expects to complete the financial statements and file its
quarterly report on Form 10 KSB on or before November 14, 2001.
The Company has filed all other reports required since reporting
requirements were instituted.
There are not any significant changes anticipated in the results of
operations from the corresponding period of the last fiscal year that will
be reflected by the earnings statements to be included in the subject
report portion thereof.
Part IV - Other Information
1. Name and telephone number of person to contact in regard to this
notification
Jonathan Neville (801) 523-0101
--------------------- --------- -----------------
Name Area Code Telephone Number
2. Have all other reports required under Section 13 or 15 (b) of the
Securities and Exchange Act of 1934 or Section 30 or the Investments
Act of 1940 during the preceding 12 months (or for such shorter)
period that the Registrant was required to file such reports been
filed? If answer is no, identify report(s).
Yes X No
------ ------
3. There are not any significant changes anticipated in the results of
operations from the corresponding period of the last fiscal year that
will be reflected by the earnings statements to be included in the
subject report portion thereof.
BioPulse International, Inc.
--------------------------------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: October 30, 2001 /s/ Jonathan Neville
-------------------------
Jonathan Neville,
Chief Executive Officer & Director